Last 12 months
Inside the activity.
1 purchase rows · 16 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 15 |
| Mar 2026 | 1 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 06, 2024 Filed Jun 10, 2024 20:19 UTC |
FRIESON RONDirector
|
GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-004905 · primarydocument.xml · nonDerivative · entry 1 FRIESON RON · CIK 0001890219 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,700 F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the "2023 Plan"), as provided by the Issuer's Third Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| May 13, 2024 Filed May 14, 2024 16:04 UTC |
Dahan MichelSVP, Chief Operating Officer
|
SaleCommon Stock | 34,840 | $1.26 | $43,898.40 |
DisclosureSEC source: 0001562180-24-004025 · primarydocument.xml · nonDerivative · entry 1 Dahan Michel · CIK 0001669737 · SVP, Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 672,092 F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on May 12, 2023. F2 · shares: This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 3, 2023. Read SEC document |
| May 13, 2024 Filed May 14, 2024 20:05 UTC |
Hadas Nicole R.SVP, Chief Legal Officer
|
SaleCommon Stock | 12,016 | $1.26 | $15,140.16 |
DisclosureSEC source: 0001562180-24-004026 · primarydocument.xml · nonDerivative · entry 1 Hadas Nicole R. · CIK 0001602396 · SVP, Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 651,243 F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on May 12, 2023. F2 · shares: This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2023. Read SEC document |
| February 29, 2024 Filed Mar 1, 2024 17:49 UTC |
Dahan MichelSVP, Chief Operating Officer
|
SaleCommon Stock | 8,661 | $1.58 | $13,684.38 |
DisclosureSEC source: 0001562180-24-002023 · primarydocument.xml · nonDerivative · entry 1 Dahan Michel · CIK 0001669737 · SVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 706,932 F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2022. Read SEC document |
| February 29, 2024 Filed Mar 1, 2024 22:48 UTC |
Hadas Nicole R.SVP, Chief Legal Officer
|
SaleCommon Stock | 5,974 | $1.58 | $9,438.92 |
DisclosureSEC source: 0001562180-24-002022 · primarydocument.xml · nonDerivative · entry 1 Hadas Nicole R. · CIK 0001602396 · SVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 663,259 F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2022. Read SEC document |
| February 29, 2024 Filed Mar 1, 2024 22:47 UTC |
Butler John P.Director · CEO and President
|
SaleCommon Stock | 46,570 | $1.58 | $73,580.60 |
DisclosureSEC source: 0001562180-24-002021 · primarydocument.xml · nonDerivative · entry 1 Butler John P. · CIK 0001591467 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,044,580 F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2022. Read SEC document |
| February 29, 2024 Filed Mar 1, 2024 22:46 UTC |
Burke Steven KeithSVP, Chief Medical Officer
|
SaleCommon Stock | 7,169 | $1.58 | $11,327.02 |
DisclosureSEC source: 0001562180-24-002020 · primarydocument.xml · nonDerivative · entry 1 Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 695,840 F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 28, 2022. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 18:02 UTC |
Dahan MichelSVP, Chief Operating Officer
|
SaleCommon Stock | 10,744 | $1.52 | $16,330.88 |
DisclosureSEC source: 0001562180-24-001994 · primarydocument.xml · nonDerivative · entry 1 Dahan Michel · CIK 0001669737 · SVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 715,593 F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 26, 2021. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 23:03 UTC |
Hadas Nicole R.SVP, Chief Legal Officer
|
SaleCommon Stock | 7,411 | $1.52 | $11,264.72 |
DisclosureSEC source: 0001562180-24-001995 · primarydocument.xml · nonDerivative · entry 1 Hadas Nicole R. · CIK 0001602396 · SVP, Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 669,233 F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 26, 2021. F2 · shares: This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2023. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 23:01 UTC |
Burke Steven KeithSVP, Chief Medical Officer
|
SaleCommon Stock | 8,367 | $1.52 | $12,717.84 |
DisclosureSEC source: 0001562180-24-001993 · primarydocument.xml · nonDerivative · entry 1 Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 703,009 F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 26, 2021. F2 · shares: This sale was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2023. Read SEC document |
| February 27, 2024 Filed Feb 29, 2024 23:00 UTC |
Butler John P.Director · CEO and President
|
SaleCommon Stock | 37,733 | $1.52 | $57,354.16 |
DisclosureSEC source: 0001562180-24-001992 · primarydocument.xml · nonDerivative · entry 1 Butler John P. · CIK 0001591467 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,091,150 F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on February 26, 2021. Read SEC document |
| February 01, 2024 Filed Feb 2, 2024 21:10 UTC |
Butler John P.Director · CEO and President
|
SaleCommon Stock | 46,489 | $1.68 | $78,101.52 |
DisclosureSEC source: 0001562180-24-000971 · primarydocument.xml · nonDerivative · entry 2 Butler John P. · CIK 0001591467 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,128,883 F3 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31,2023. Read SEC document |
| February 01, 2024 Filed Feb 2, 2024 21:10 UTC |
Burke Steven KeithSVP, Chief Medical Officer
|
SaleCommon Stock | 24,311 | $1.68 | $40,842.48 |
DisclosureSEC source: 0001562180-24-000970 · primarydocument.xml · nonDerivative · entry 2 Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 711,376 F3 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on January 31,2023. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 16:11 UTC |
Dahan MichelSVP, Chief Operating Officer
|
GrantStock Option (Right to buy) · Derivative | 224,000 | $0.00 Strike: $1.68 | $0.00 |
DisclosureSEC source: 0001562180-24-000978 · primarydocument.xml · derivative · entry 2 Dahan Michel · CIK 0001669737 · SVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 224,000 Underlying: Common Stock · 224,000 shares Expires 2034-01-31 F3 · derivative.exercise_date: The options were granted by the Issuer pursuant to its 2023 Stock Incentive Plan. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 16:11 UTC |
Dahan MichelSVP, Chief Operating Officer
|
GrantCommon Stock | 149,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-000978 · primarydocument.xml · nonDerivative · entry 1 Dahan Michel · CIK 0001669737 · SVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 726,337 F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2023 Stock Incentive Plan. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date. F2 · balance_after: Includes 1,500 shares of the Issuer's common stock purchased on June 30, 2023 and 1,500 shares of the Issuer's common stock purchased on December 29, 2023, each under the Issuer's Amended and Restated 2014 Employee Stock Purchase Plan. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 21:11 UTC |
Grund NicholasChief Commercial Officer
|
GrantStock Option (Right to buy) · Derivative | 454,950 | $0.00 Strike: $1.68 | $0.00 |
DisclosureSEC source: 0001562180-24-000983 · primarydocument.xml · derivative · entry 2 Grund Nicholas · CIK 0001661887 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 454,950 Underlying: Common Stock · 454,950 shares Expires 2034-01-31 F2 · derivative.exercise_date: The options were granted by the Issuer as an inducement material to the reporting person's entering into employment with the Issuer in accordance with Nasdaq Listing Rule 5635(c)(4). The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 21:11 UTC |
Grund NicholasChief Commercial Officer
|
GrantCommon Stock | 303,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-000983 · primarydocument.xml · nonDerivative · entry 1 Grund Nicholas · CIK 0001661887 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 303,300 F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2023 Stock Incentive Plan. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 21:11 UTC |
Malabre Richard CChief Accounting Officer
|
GrantStock Option (Right to buy) · Derivative | 336,000 | $0.00 Strike: $1.68 | $0.00 |
DisclosureSEC source: 0001562180-24-000980 · primarydocument.xml · derivative · entry 2 Malabre Richard C · CIK 0002007730 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 336,000 Underlying: Common Stock · 336,000 shares Expires 2034-01-31 F2 · derivative.exercise_date: The options were granted by the Issuer as an inducement material to the reporting person's entering into employment with the Issuer in accordance with Nasdaq Listing Rule 5635(c)(4). The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 21:11 UTC |
Malabre Richard CChief Accounting Officer
|
GrantCommon Stock | 223,950 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-000980 · primarydocument.xml · nonDerivative · entry 1 Malabre Richard C · CIK 0002007730 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 223,950 F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2023 Stock Incentive Plan. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 21:10 UTC |
Snow EllenSVP, CFO and Treasurer
|
GrantStock Option (Right to buy) · Derivative | 224,000 | $0.00 Strike: $1.68 | $0.00 |
DisclosureSEC source: 0001562180-24-000975 · primarydocument.xml · derivative · entry 2 Snow Ellen · CIK 0001786643 · SVP, CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 224,000 Underlying: Common Stock · 224,000 shares Expires 2034-01-31 F2 · derivative.exercise_date: The options were granted by the Issuer pursuant to its 2023 Stock Incentive Plan. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 21:10 UTC |
Snow EllenSVP, CFO and Treasurer
|
GrantCommon Stock | 149,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-000975 · primarydocument.xml · nonDerivative · entry 1 Snow Ellen · CIK 0001786643 · SVP, CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 519,300 F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2023 Stock Incentive Plan. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 21:10 UTC |
Hadas Nicole R.SVP, Chief Legal Officer
|
GrantStock Option (Right to buy) · Derivative | 224,000 | $0.00 Strike: $1.68 | $0.00 |
DisclosureSEC source: 0001562180-24-000973 · primarydocument.xml · derivative · entry 2 Hadas Nicole R. · CIK 0001602396 · SVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 224,000 Underlying: Common Stock · 224,000 shares Expires 2034-01-31 F3 · derivative.exercise_date: The options were granted by the Issuer pursuant to its 2023 Stock Incentive Plan. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 21:10 UTC |
Hadas Nicole R.SVP, Chief Legal Officer
|
GrantCommon Stock | 149,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-000973 · primarydocument.xml · nonDerivative · entry 1 Hadas Nicole R. · CIK 0001602396 · SVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 676,644 F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2023 Stock Incentive Plan. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date. F2 · balance_after: Includes 1,500 shares of the Issuer's common stock purchased on June 30, 2023 and 1,500 shares of the Issuer's common stock purchased on December 29, 2023, each under the Issuer's Amended and Restated 2014 Employee Stock Purchase Plan. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 21:10 UTC |
Butler John P.Director · CEO and President
|
GrantStock Option (Right to buy) · Derivative | 905,200 | $0.00 Strike: $1.68 | $0.00 |
DisclosureSEC source: 0001562180-24-000971 · primarydocument.xml · derivative · entry 7 Butler John P. · CIK 0001591467 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 905,200 Underlying: Common Stock · 905,200 shares Expires 2034-01-31 F4 · derivative.exercise_date: The options were granted by the Issuer pursuant to its 2023 Stock Incentive Plan. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 21:10 UTC |
Butler John P.Director · CEO and President
|
GrantCommon Stock | 603,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-000971 · primarydocument.xml · nonDerivative · entry 1 Butler John P. · CIK 0001591467 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,175,372 F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2023 Stock Incentive Plan. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date. F2 · balance_after: Includes 1,500 shares of the Issuer's common stock purchased on June 30, 2023 and 1,500 shares of the Issuer's common stock purchased on December 29, 2023, each under the Issuer's Amended and Restated 2014 Employee Stock Purchase Plan. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 21:10 UTC |
Burke Steven KeithSVP, Chief Medical Officer
|
GrantStock Option (Right to buy) · Derivative | 303,300 | $0.00 Strike: $1.68 | $0.00 |
DisclosureSEC source: 0001562180-24-000970 · primarydocument.xml · derivative · entry 3 Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 303,300 Underlying: Common Stock · 303,300 shares Expires 2034-01-31 F4 · derivative.exercise_date: The options were granted by the Issuer pursuant to its 2023 Stock Incentive Plan. The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the reporting person's continued service with the Issuer on each vesting date. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 21:10 UTC |
Burke Steven KeithSVP, Chief Medical Officer
|
GrantCommon Stock | 202,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-000970 · primarydocument.xml · nonDerivative · entry 1 Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 735,687 F1 · shares: The restricted stock units were granted by the Issuer pursuant to its 2023 Stock Incentive Plan. One third of the restricted stock units will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date. F2 · balance_after: Includes 1,500 shares of the Issuer's common stock purchased on June 30, 2023 and 1,500 shares of the Issuer's common stock purchased on December 29, 2023, each under the Issuer's Amended and Restated 2014 Employee Stock Purchase Plan. Read SEC document |
| August 25, 2023 Filed May 9, 2024 21:27 UTC |
Burke Steven KeithSVP, Chief Medical Officer
|
SaleCommon Stock | 27,000 | $1.15 | $31,050.00 |
DisclosureSEC source: 0001562180-24-003948 · primarydocument.xml · nonDerivative · entry 1 Burke Steven Keith · CIK 0001619834 · SVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 668,840 Read SEC document |
| July 31, 2023 Filed Aug 1, 2023 20:35 UTC |
Snow EllenSVP, CFO and Treasurer
|
GrantStock Option (Right to buy) · Derivative | 560,000 | $0.00 Strike: $1.67 | $0.00 |
DisclosureSEC source: 0001562180-23-006088 · primarydocument.xml · derivative · entry 2 Snow Ellen · CIK 0001786643 · SVP, CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 560,000 Underlying: Common Stock · 560,000 shares Expires 2033-07-31 F2 · derivative.exercise_date: The options were granted by the Issuer as an inducement material to the Reporting Person's entering into employment with the Issuer in accordance with Nasdaq Listing Rule 5635(c)(4). The options will vest over four years: 25% of the options will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| July 31, 2023 Filed Aug 1, 2023 20:35 UTC |
Snow EllenSVP, CFO and Treasurer
|
GrantCommon Stock | 370,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-006088 · primarydocument.xml · nonDerivative · entry 1 Snow Ellen · CIK 0001786643 · SVP, CFO and Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 370,000 F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan. One third of the RSUs will vest upon each of the first, second and third anniversaries of the grant date, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 20:07 UTC |
Wolf MylesDirector
|
GrantStock Option (Right to buy) · Derivative | 45,000 | $0.00 Strike: $1.20 | $0.00 |
DisclosureSEC source: 0001562180-23-004957 · primarydocument.xml · derivative · entry 2 Wolf Myles · CIK 0001808317 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2033-06-06 F2 · derivative.exercise_date: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 20:07 UTC |
Wolf MylesDirector
|
GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-004957 · primarydocument.xml · nonDerivative · entry 1 Wolf Myles · CIK 0001808317 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,681 F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the "2023 Plan"), as provided by the Issuer's Second Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 20:07 UTC |
ADAMS ADRIANDirector
|
GrantStock Option (Right to buy) · Derivative | 45,000 | $0.00 Strike: $1.20 | $0.00 |
DisclosureSEC source: 0001562180-23-004956 · primarydocument.xml · derivative · entry 2 ADAMS ADRIAN · CIK 0001248144 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2033-06-06 F2 · derivative.exercise_date: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 20:07 UTC |
ADAMS ADRIANDirector
|
GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-004956 · primarydocument.xml · nonDerivative · entry 1 ADAMS ADRIAN · CIK 0001248144 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 134,800 F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the "2023 Plan"), as provided by the Issuer's Second Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 20:08 UTC |
ROGERS MICHAEL WDirector
|
GrantStock Option (Right to buy) · Derivative | 45,000 | $0.00 Strike: $1.20 | $0.00 |
DisclosureSEC source: 0001562180-23-004959 · primarydocument.xml · derivative · entry 2 ROGERS MICHAEL W · CIK 0001244159 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2033-06-06 F2 · derivative.exercise_date: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 20:08 UTC |
ROGERS MICHAEL WDirector
|
GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-004959 · primarydocument.xml · nonDerivative · entry 1 ROGERS MICHAEL W · CIK 0001244159 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,029 F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the "2023 Plan"), as provided by the Issuer's Second Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 20:08 UTC |
ZUMWALT LEANNE MDirector
|
GrantStock Option (Right to buy) · Derivative | 45,000 | $0.00 Strike: $1.20 | $0.00 |
DisclosureSEC source: 0001562180-23-004960 · primarydocument.xml · derivative · entry 2 ZUMWALT LEANNE M · CIK 0001204946 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2033-06-06 F2 · derivative.exercise_date: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 20:08 UTC |
ZUMWALT LEANNE MDirector
|
GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-004960 · primarydocument.xml · nonDerivative · entry 1 ZUMWALT LEANNE M · CIK 0001204946 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,700 F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the "2023 Plan"), as provided by the Issuer's Second Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 16:07 UTC |
GILMAN STEVEN CDirector
|
GrantStock Option (Right to buy) · Derivative | 45,000 | $0.00 Strike: $1.20 | $0.00 |
DisclosureSEC source: 0001562180-23-004954 · primarydocument.xml · derivative · entry 2 GILMAN STEVEN C · CIK 0001379970 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2033-06-06 F2 · derivative.exercise_date: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 16:07 UTC |
GILMAN STEVEN CDirector
|
GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-004954 · primarydocument.xml · nonDerivative · entry 1 GILMAN STEVEN C · CIK 0001379970 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,130 F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the "2023 Plan"), as provided by the Issuer's Second Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 20:07 UTC |
FRIESON RONDirector
|
GrantStock Option (Right to buy) · Derivative | 45,000 | $0.00 Strike: $1.20 | $0.00 |
DisclosureSEC source: 0001562180-23-004958 · primarydocument.xml · derivative · entry 2 FRIESON RON · CIK 0001890219 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2033-06-06 F2 · derivative.exercise_date: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 20:07 UTC |
FRIESON RONDirector
|
GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-004958 · primarydocument.xml · nonDerivative · entry 1 FRIESON RON · CIK 0001890219 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,700 F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the "2023 Plan"), as provided by the Issuer's Second Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 20:07 UTC |
Smith CynthiaDirector
|
GrantStock Option (Right to buy) · Derivative | 45,000 | $0.00 Strike: $1.20 | $0.00 |
DisclosureSEC source: 0001562180-23-004955 · primarydocument.xml · derivative · entry 2 Smith Cynthia · CIK 0001609480 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2033-06-06 F2 · derivative.exercise_date: The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 20:07 UTC |
Smith CynthiaDirector
|
GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-004955 · primarydocument.xml · nonDerivative · entry 1 Smith Cynthia · CIK 0001609480 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,233 F1 · shares: The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the "2023 Plan"), as provided by the Issuer's Second Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| May 25, 2023 Filed May 25, 2023 21:01 UTC |
Dahan MichelSVP, Chief Operating Officer
|
SaleCommon Stock | 95,478 | $1.22 | $116,760.05 |
DisclosureSEC source: 0001562180-23-004503 · primarydocument.xml · nonDerivative · entry 2 Dahan Michel · CIK 0001669737 · SVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 574,037 F2 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of all of the PSUs. Read SEC document |
| May 25, 2023 Filed May 26, 2023 01:01 UTC |
Hadas Nicole R.SVP, Chief Legal Officer
|
SaleCommon Stock | 63,186 | $1.22 | $77,270.16 |
DisclosureSEC source: 0001562180-23-004504 · primarydocument.xml · nonDerivative · entry 2 Hadas Nicole R. · CIK 0001602396 · SVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 524,344 F2 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of all of the PSUs. Read SEC document |
| May 24, 2023 Filed May 25, 2023 21:01 UTC |
Dahan MichelSVP, Chief Operating Officer
|
GrantEmployee Stock Option (Right to buy) · Derivative | 200,000 | $0.00 Strike: $0.41 | $0.00 |
DisclosureSEC source: 0001562180-23-004503 · primarydocument.xml · derivative · entry 3 Dahan Michel · CIK 0001669737 · SVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2032-05-12 F3 · derivative.exercise_date: As previously disclosed, in May 2022, the Reporting Person was granted performance-based options (the "Options") pursuant to the Issuer's 2014 Incentive Plan, as amended. The Options vest upon the closing of a significant transaction as defined in the award agreements. On May 24, 2023, the Company entered into a License Agreement, which transaction qualified as a significant transaction and closed on May 24, 2023. As a result, all of the shares subject to the Option vested on May 24, 2023. Read SEC document |
| May 24, 2023 Filed May 25, 2023 21:01 UTC |
Dahan MichelSVP, Chief Operating Officer
|
GrantCommon Stock | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-004503 · primarydocument.xml · nonDerivative · entry 1 Dahan Michel · CIK 0001669737 · SVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 669,515 F1 · shares: As previously disclosed, in May 2022, the Reporting Person was granted performance-based restricted stock units ("PSUs") pursuant to the Issuer's 2014 Incentive Plan, as amended. The PSUs vest upon the closing of a significant transaction as defined in the award agreement. On May 24, 2023, the Company entered into a License Agreement, which transaction qualified as a significant transaction and closed on May 24, 2023. As a result, all of the PSUs vested on May 24, 2023 Read SEC document |
| May 24, 2023 Filed May 26, 2023 01:01 UTC |
Hadas Nicole R.SVP, Chief Legal Officer
|
GrantEmployee Stock Option (Right to buy) · Derivative | 200,000 | $0.00 Strike: $0.41 | $0.00 |
DisclosureSEC source: 0001562180-23-004504 · primarydocument.xml · derivative · entry 3 Hadas Nicole R. · CIK 0001602396 · SVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2032-05-12 F3 · derivative.exercise_date: As previously disclosed, in May 2022, the Reporting Person was granted performance-based options (the "Options") pursuant to the Issuer's 2014 Incentive Plan, as amended. The Options vest upon the closing of a significant transaction as defined in the award agreements. On May 24, 2023, the Company entered into a License Agreement, which transaction qualified as a significant transaction and closed on May 24, 2023. As a result, all of the shares subject to the Option vested on May 24, 2023. Read SEC document |
| May 24, 2023 Filed May 26, 2023 01:01 UTC |
Hadas Nicole R.SVP, Chief Legal Officer
|
GrantCommon Stock | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-004504 · primarydocument.xml · nonDerivative · entry 1 Hadas Nicole R. · CIK 0001602396 · SVP, Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 587,530 F1 · shares: As previously disclosed, in May 2022, the Reporting Person was granted performance-based restricted stock units ("PSUs") pursuant to the Issuer's 2014 Incentive Plan, as amended. The PSUs vest upon the closing of a significant transaction as defined in the award agreement. On May 24, 2023, the Company entered into a License Agreement, which transaction qualified as a significant transaction and closed on May 24, 2023. As a result, all of the PSUs vested on May 24, 2023 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.